The Fourth Annual Jazz Half Marathon and 5K

Join us for the Fourth Annual Jazz Half Marathon & 5K on Saturday, October 27, 2012 and help support the Cancer Program here at Children's Hospital. This year's races will be televised live on NBC-affiliate 6 WDSU, and will start and finish at the beautiful Lafayette Square Park in the New Orleans CBD. Runners will run past such landmarks as the New Orleans Convention Center, Louisiana Superdome, and the statue of Robert E. Lee at Lee Circle. From Lee Circle, runners will run up the Grand Dame of New Orleans streets, St. Charles Avenue, passing the fabled mansions of the Garden District, Loyola and Tulane Universities and through the green expanse of Audubon Park. Coming back downtown, you’ll run past the World War II Museum, Contemporary Arts Museum and Ogden Museum of Southern Art before finishing the race at Lafayette Square. Along the way, you will be treated to a wealth of New Orleans music by local bands.


After the race, you will feast on great food, beer, water, and soft drinks while dancing to the music of top New Orleans bands. All participants in the Jazz Half Marathon will receive gender-specific, Jazz Half-logo, tech shirts and runners in the 5K will all receive Merrill Lynch 5K-logo, all cotton tee shirts. The first 3000 Half Marathon and 1000 5K finishers will also receive beautiful finishers' medallions.


By running the Jazz Half Marathon and 5K, you will also be supporting the Cancer Program at Children’s Hospital. Children's Hospital treats more Louisiana kids with cancer than all other facilities combined. Children’s Hospital's LaNasa-Greco Center for Cancer and Blood Disorders treats more than 1,100 children with cancer each year, and our hospital has a policy of never turning away a child who needs the care we offer, regardless of the family's ability to pay. The hospital provides treatment for children with leukemia, lymphoma, tumors, anemia, hemophilia, and other childhood cancers. As a member of the Children’s Oncology Group, hospital physicians have access to the most up-to-date therapies for treatment of malignancies and blood disorders in children.